SCHEMBL29440252

SCHEMBL29440252

Oc1ccc2[nH]ccc2c1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
USP2 O75604 1/20 1.00
GAA P10253 1/20 1.00
ALOX15 P16050 1/20 1.00
RAD51 Q06609 1/20 1.00
NPSR1 Q6W5P4 1/20 1.00
TYR P14679 1/20 0.68
MAOB P27338 1/20 0.56
AHR P35869 4/20 0.56
NR4A2 P43354 2/20 0.56
CYP2A6 P11509 2/20 0.56
F7 P08709 1/20 0.56
LTA4H P09960 1/20 0.56
F3 P13726 1/20 0.56
F2 P00734 1/20 0.52
GUSB P08236 3/20 0.51
IMPDH2 P12268 1/20 0.50
IMPDH1 P20839 1/20 0.50
NPC1 O15118 1/20 0.50
CYP1A2 P05177 1/20 0.48
CYP3A4 P08684 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL50566 1.00 USP2 (1.00) USP2GAAALOX15RAD51NPSR1
Hydrochloric Acid SCHEMBL4718421 0.98 USP2 (0.95) USP2GAAALOX15RAD51NPSR1
Water SCHEMBL28220544 0.98 USP2 (0.95) USP2GAAALOX15RAD51NPSR1
Bromide SCHEMBL6029763 0.98 USP2 (0.95) USP2GAAALOX15RAD51NPSR1
SCHEMBL5447196 0.92 TYR (0.84) USP2GAAALOX15RAD51NPSR1
Indole SCHEMBL4974902 0.90 USP2 (0.81) USP2GAAALOX15RAD51NPSR1
Acetic Acid SCHEMBL122895 0.88 USP2 (0.78) USP2GAAALOX15RAD51NPSR1
Acetaldehyde SCHEMBL308459 0.88 USP2 (0.78) USP2GAAALOX15RAD51NPSR1
SCHEMBL4542260 0.84 USP2 (0.70) USP2GAAALOX15RAD51NPSR1
Trifluoroacetic Acid SCHEMBL30029434 0.84 USP2 (0.70) USP2GAAALOX15RAD51NPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 38 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025083271-A1 BACTERIAL COMPOSITION COMPRISING AKKERMANSIA SPECIES, FOR IMPROVING THE RESPONSE TO CAR T-CELL THERAPY INSTITUT GUSTAVE ROUSSY (FR) 2025-04-24 WO claimed
EP-4373483-A1 COMBINATION OF A KETONE BODY OR KETOGENIC COMPOUND WITH AN ANALGESIC OR ANTIOXIDANT KetoSwiss AG (CH) 2024-05-29 EP claimed
WO-2024095177-A1 MANGANESE BIFUNCTIONAL CHELATING AGENT CONJUGATION PLATFORM FOR TARGETED MR IMAGING THE GOVERNING COUNCIL OF THE UNIVERSITY OF TORONTO (CA) 2024-05-10 WO claimed
WO-2023205769-A1 A CHEMOSELECTIVE PHOTOCHEMICAL BIOCONJUGATION REACTION AND METHODS OF USE THEREOF TRUSTEES OF BOSTON COLLEGE (US) 2023-10-26 WO claimed
WO-2023001724-A1 COMBINATION OF A KETONE BODY OR KETOGENIC COMPOUND WITH AN ANALGESIC OR ANTIOXIDANT KETOSWISS AG (CH) 2023-01-26 WO claimed
EP-3977112-A1 MASS SPECTROMETRY ASSAY METHODS FOR DETECTION OF METABOLITES Metabolon Inc. (US) 2022-04-06 EP claimed
US-20220047711-A1 PHOTOCROSSLINKING PEPTIDES FOR SITE SPECIFIC CONJUGATION TO FC-CONTAINING PROTEINS GENENTECH, INC. (US) 2022-02-17 US claimed
WO-2025231196-A1 MODIFIED BRUCELLA STRAINS AND METHODS OF USE FOR TREATMENT OF DISEASE THE TEXAS A&M UNIVERSITY SYSTEM (US) 2025-11-06 WO disclosed
WO-2025231196-A1 MODIFIED BRUCELLA STRAINS AND METHODS OF USE FOR TREATMENT OF DISEASE THE TEXAS A&M UNIVERSITY SYSTEM (US) 2025-11-06 WO disclosed
WO-2025133938-A1 A HAIR BLEACH AND COLOUR DEPOSITION FORMULATION AND METHOD OF PREPARATION THEREOF MARICO LIMITED (IN) 2025-06-26 WO disclosed
US-20250170194-A1 MICROBIAL COMPOSITIONS AND METHODS FOR PRODUCING UPGRADED PROBIOTIC ASSEMBLAGES SOLAREA BIO INC (US) 2025-05-29 US disclosed
WO-2025064458-A1 PREVENTION AND TREATMENT OF VIRAL INFECTIONS BARANOWITZ STEVEN (US) 2025-03-27 WO disclosed
WO-2025054293-A1 BIOMARKER FOR PROSTATE CANCER NATIONAL TAIWAN UNIVERSITY (TW) 2025-03-13 WO disclosed
WO-2022232931-A1 CATALYTIC TRYPTAMINE PROCESSES AND PRECURSORS KARE CHEMICAL TECHNOLOGIES INC. (CA) 2022-11-10 WO disclosed
EP-4076542-A1 HIGHLY EFFICIENT MYELOPEROXIDASE ACTIVATABLE IMAGING AGENTS The General Hospital Corporation (US) 2022-10-26 EP disclosed
EP-3752838-B1 METHOD FOR DETERMINING THE TOTAL HISTAMINE DEGRADATION CAPACITY IN BIOLOGICAL SAMPLES FROST DIAGNOSTIKA GMBH (DE) 2022-08-03 EP disclosed
EP-4017281-A1 PET FOOD COMPOSITIONS Hill's Pet Nutrition, Inc. (US) 2022-06-29 EP disclosed
WO-2022115625-A1 PROTEIN DERIVATIVES CONTAINING UNNATURAL AMINO ACIDS AND BRANCHED LINKERS BRICKBIO, INC. (US) 2022-06-02 WO disclosed
WO-2022056318-A1 ANTIBODIES CONTAINING UNNATURAL AMINO ACIDS AND METHODS OF MAKING AND USING THE SAME BRICKBIO, INC. (US) 2022-03-17 WO disclosed
US-20220047711-A1 PHOTOCROSSLINKING PEPTIDES FOR SITE SPECIFIC CONJUGATION TO FC-CONTAINING PROTEINS GENENTECH, INC. (US) 2022-02-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220047711-A1 PHOTOCROSSLINKING PEPTIDES FOR SITE SPECIFIC CONJUGATION TO FC-CONTAINING PROTEINS FCGR2A, FCGR3B, DNPEP USP2 1635/4885GAA 4013/4885ALOX15 3579/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.